Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
<p>Abstract</p> <p>Background</p> <p>The atheroprotective effects of systemic delivery of either apolipoprotein A-I (wtApoA-I) or the naturally occurring mutant ApoA-I Milano (ApoA-I<sub>M</sub>) have been established in animal and human trials, but direct comparison studies evaluating the phenotype...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2007-05-01
|
| シリーズ: | Cardiovascular Diabetology |
| オンライン･アクセス: | http://www.cardiab.com/content/6/1/15 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|